Exoskeleton Market Size & Growth Projections

The global exoskeleton market was valued at USD 590.0 million in 2025 and is estimated at USD 694.5 million in 2026. It is forecast to reach USD 1,790.0 million by 2033, expanding at a 14.5% CAGR from 2026 to 2033. In practical terms, the market adds about USD 1,095.5 million in annual revenue between 2026 and 2033 and ends up roughly three times its 2025 size.

What is driving growth?

The biggest driver is the rising number of people with spinal cord injuries. The World Health Organization reported in 2024 that more than 15 million people live with one. The United Spinal Association estimates 250,000 to 390,000 people in the U.S. live with spinal cord injuries, with around 18,000 new cases each year. A growing geriatric population, rising stroke incidence, and industrial adoption in automotive, construction, and defense add further demand.

What is holding it back?

High procurement cost is the main restraint. Beyond the purchase price, buyers also pay for customization, training, maintenance, and software upgrades. Uncertain reimbursement makes this harder for smaller clinics and for patients.

Download a free sample report or claim your copy of this full market intelligence report

Where is the biggest opportunity?

Home-based and community rehabilitation. Lighter designs, better batteries, and AI-driven control are making devices usable outside supervised clinics.

Key Exoskeleton Market Segments

The report splits the exoskeleton market by mobility, technology, extremity, end use, and region.

Mobility: mobile systems lead

Mobile exoskeletons held a 62.6% share in 2025 and are expected to grow fastest. Fixed or stationary systems are forecast to grow at only 1.7% CAGR, but they stay relevant for gait training in hospitals.

Technology: powered leads, non-powered accelerates

Powered systems held 71.4% of revenue in 2025. Non-powered systems are forecast to grow fastest at 17.4% CAGR. They use springs and elastic mechanisms, need no external power, and cost less, which suits logistics, construction, and manufacturing.

Extremity: lower body dominates

Lower-body exoskeletons captured 40.7% of revenue in 2025. Upper-body devices are expected to grow fastest at 16.7% CAGR, driven by stroke and musculoskeletal rehabilitation.

End use: healthcare leads, industry accelerates

Healthcare held a 48.8% share in 2025. The industry segment is forecast to grow fastest at 17.1% CAGR, as employers try to reduce occupational injuries. Festool's ExoActive, for example, is designed to cut shoulder and arm strain by up to 30% during overhead work.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs

Regional view

North America led with 44.1% of revenue in 2025. Asia Pacific is the fastest-growing region at 18.6% CAGR, followed by Latin America and Middle East & Africa at 15.3% each, and Europe at 11.6%.

Leading Industry Players in the Exoskeleton Market

Grand View Research describes the exoskeleton market as highly competitive and moderately fragmented. The key players it names are:

• Ekso Bionics
• Lockheed Martin Corporation
• Suit X
• Rex Bionics Plc.
• Lifeward Ltd.
• Cyberdyne, Inc.
• ActiveLink (Panasonic Corporation)

The report also profiles ARMASTEC PTE. LTD, RB3D, and DIH Medical.

Recent moves show where competition is heading. Lifeward launched the ReWalk 7 Personal Exoskeleton across the U.S. in April 2025. German Bionic's AI-powered Exia offers adaptive lift assistance of up to 38 kg. Wandercraft raised USD 75 million in Series D funding in June 2025. Its Atalante X system has FDA clearance and is deployed in more than 100 U.S. hospitals and clinics. In January 2026, Ekso Bionics announced a proposed merger with Applied Digital that could lead to the separation or sale of its exoskeleton business.

Explore Our Dedicated Business Service – 

Grand View Signal – Commodity Pricing Intelligence - Grand View Signal is a pricing intelligence platform that delivers monthly price assessments, historical benchmarks, forward outlook and risk valuation. It turns complex pricing data into clear insights, helping leaders make better decisions and reduce risk through a simple three-stage workflow. 

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.